Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NHS England
Pharma
Pharma industry reaches 'landmark' drug spending deal with UK
The U.K. government has agreed to increase the allowed annual revenue growth rate for branded drugs from 2% in 2024 to 4% by 2027.
Angus Liu
Nov 20, 2023 11:00am
Novartis scraps key UK Leqvio study
Mar 22, 2023 11:55am
AbbVie, Lilly exit UK pricing accord over 'punitive' clawbacks
Jan 17, 2023 10:45am
Bayer's Nubeqa debuts in new use across the pond
Nov 28, 2022 10:34am
UK government press for Rx meds ‘often overtly promotional': BMJ
Sep 28, 2022 9:20am
U.K. delays nod for Evrysdi but makes it available to patients
Nov 19, 2021 2:58am
